Clinical Trial Update: A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 clinical trial studying apatinib in combination with tegafur gimeracil oteracil for locally advanced head and neck squamous cell carcinoma has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• tegafur gimeracil oteracil (tegafur gimeracil oteracil)

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED